227 related articles for article (PubMed ID: 29784739)
21. [Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: initial results of the CAO/ARO/AIO-04 study].
Reibetanz J; Germer CT
Chirurg; 2012 Nov; 83(11):995. PubMed ID: 23089949
[No Abstract] [Full Text] [Related]
22. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
23. Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus.
Siavashpour Z; Taghizadeh-Hesary F; Rakhsha A
J Gastrointest Cancer; 2020 Sep; 51(3):800-804. PubMed ID: 32656628
[TBL] [Abstract][Full Text] [Related]
24. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
25. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
26. Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience.
Gilshtein H; Ghuman A; Dawoud M; Yellinek S; Kent I; Sharp SP; Nagarajan A; Wexner SD
Am Surg; 2021 May; 87(5):708-713. PubMed ID: 33169626
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
28. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
29. Rectal cancer clinical practice guidelines in oncology.
Engstrom PF; Benson AB; Chen YJ; Choti MA; Dilawari RA; Enke CA; Fakih MG; Fuchs C; Kiel K; Knol JA; Leong LA; Ludwig KA; Martin EW; Rao S; Saif MW; Saltz L; Skibber JM; Venook AP; Yeatman TJ;
J Natl Compr Canc Netw; 2005 Jul; 3(4):492-508. PubMed ID: 16038640
[No Abstract] [Full Text] [Related]
30. Pathologic complete response after FOLFOX7 in a locally advanced rectal cancer.
Li J; Rose MG; Perkal MF; Chao HH
J Clin Gastroenterol; 2012 Jan; 46(1):87-8. PubMed ID: 22157222
[No Abstract] [Full Text] [Related]
31. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO
Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemoradiation therapy using concurrent S-1 and irinotecan in rectal cancer: impact on long-term clinical outcomes and prognostic factors.
Nakamura T; Yamashita K; Sato T; Ema A; Naito M; Watanabe M
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):547-55. PubMed ID: 24929164
[TBL] [Abstract][Full Text] [Related]
33. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
34. Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial.
Cheng YK; Qin QY; Huang XY; Lan P; Wang L; Gao X; Ma TH
Cancer Med; 2020 Feb; 9(3):912-919. PubMed ID: 31828956
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?
Hong TS; Ryan DP
J Clin Oncol; 2015 Jun; 33(17):1878-80. PubMed ID: 25940719
[No Abstract] [Full Text] [Related]
36. Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response.
Patel UB; Blomqvist L; Chau I; Nicholls J; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():76-81. PubMed ID: 29878685
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer.
Kawai K; Sunami E; Hata K; Tanaka T; Nishikawa T; Otani K; Sasaki K; Nozawa H
Clin Colorectal Cancer; 2018 Sep; 17(3):240-246. PubMed ID: 29934092
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
39. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer.
You YN; Hardiman KM; Bafford A; Poylin V; Francone TD; Davis K; Paquette IM; Steele SR; Feingold DL;
Dis Colon Rectum; 2020 Sep; 63(9):1191-1222. PubMed ID: 33216491
[No Abstract] [Full Text] [Related]
40. Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
Feng YR; Jin J; Ren H; Wang X; Wang SL; Wang WH; Song YW; Liu YP; Tang Y; Li N; Liu XF; Fang H; Yu ZH; Li YX
BMC Cancer; 2017 Mar; 17(1):182. PubMed ID: 28279170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
